Ho Kyung Ko

Title: Ho Kyung Ko: Innovator in Cancer Immunotherapy

Introduction

Ho Kyung Ko is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer immunotherapy through his innovative research and patented inventions. His work focuses on developing advanced therapeutic methods to combat cancer effectively.

Latest Patents

Ho Kyung Ko holds a patent for a "Protein nanoparticle linked with cancer specific epitope and composition for cancer immunotherapy comprising the same." This invention relates to a protein nanoparticle that has a surface on which a cancer-specific epitope is fused and expressed. The patent details a method for producing this nanoparticle and a composition for cancer immunotherapy that includes it as an active ingredient. The cancer-specific epitope can be expressed with correct orientation and high density, leading to significantly improved cancer immunotherapeutic effects compared to existing nanoparticle-based compositions.

Career Highlights

Throughout his career, Ho Kyung Ko has worked with notable institutions such as the Korea University Research and Business Foundation and the Korea Institute of Science and Technology. His research has been pivotal in advancing the understanding and treatment of cancer through innovative approaches.

Collaborations

Ho Kyung Ko has collaborated with colleagues such as Jeewon Lee and Bo Ram Lee, contributing to the development of groundbreaking technologies in cancer treatment.

Conclusion

Ho Kyung Ko's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His patented inventions and collaborative efforts continue to pave the way for advancements in cancer immunotherapy.